Drug Information Analysis Service;Assessment of Thyroid Function during Phenytoin Therapy

Oppenheimer JH Fisher LV Nelson KM Jailer JW . Depression of the serum protein-bound iodine level by diphenylhydantoin. J Clin Endocrinol Metab 1961; 21: 252–62.

Caplan RH Mordon R Kristoff K Wickus G . Diphenylhydantoin effects on thyroid function tests. Ann Neurol 1977; 1: 603–4.

Stjernholm MR Alsever RN Rudolph MC . Thyroid-function tests in diphenylhydantoin-treated patients. Clin Chem 1975; 21: 1388–92.

Cavalieri RR Pitt-Rivers R . The effects of drugs on the distribution and metabolism of thyroid hormones. Pharmacol Rev 1981; 33: 55–80.

Yeo PB Bates D Howe JG . Anticonvulsants and thyroid function. Br Med J 1978; 1: 1581–3.

Cavalieri RR Gavin LA Wallace A Hammond ME Cruse K . Serum thyroxine, free T₄, triiodothyronine, and reverse-T₃ in diphenylhydantoin-treated patients. Metabolism 1979; 28: 1161–5.

Rootwelt K Ganes T Johannessen SI . Effect of carbamazepine, phenytoin, and phenobarbitone on serum levels of thyroid hormones and thyrotropin in humans. Scand J Clin Lab Invest 1978; 38: 731–6.

Franklyn JA Sheppard MC Ramsden DB . Measurement of free thyroid hormones in patients in long-term phenytoin therapy. Eur J Clin Pharmacol 1984; 26: 633–4.

Liewendahl K Tikanoja S Helenius T Majuri H . Free thyroxine and free triiodothyronine as measured by equilibrium dialysis and analog radioimmunoassay in serum of patients taking phenytoin and carbamazepine. Clin Chem 1985; 31: 1993–6.

Surks MI Ordene KW Mann DN Kumara-Siri MH . Diphenylhydantoin inhibits the thyrotropin response to thyrotropin-releasing hormone in man and rat. J Clin Endocrinol Metab 1983; 56: 940–5.

Liewendahl K Majuri H . Thyroxine, triiodothyronine, and thyrotropin in long-term diphenylhydantoin therapy. Scand J Clin Lab Invest 1976; 36; 141–4.

Heyma P Larkins RG Perry-Keene D Peter CT Ross D Sloman JG . Thyroid hormone levels and protein binding in patients on long-term diphenylhydantoin treatment. Clin Endocrinol 1977; 6: 369–76.

Suzuki H Yamazaki N Suzuki Y . Lowering effect of diphenylhydantoin on serum free thyroxine and thyroxine binding globulin (TBG). Acta Endocrinol 1984; 105; 477–81.

Hegedus L Hansen JM Luhdorf K Perrild H Feldt-Rasmussen U Kampmann JP . Increased frequency of goitre in epileptic patients on long-term phenytoin or carbamazepine treatment. Clin Endocrinol 1985; 23: 423–9.

Brecknridge A Orme M . Kinetics of warfarin absorption in man. Clin Pharmacol Ther 1973; 14: 955–61.

Mitchell JF Maas LC Barger RC Gelzayd EA . Successful oral anticoagulant therapy in a patient with short bowel syndrome. Am J Hosp Pharm 1977; 34: 171–2.

Lehman ME Kolb KW Barnhart GR Wagman LD Barr WH . Warfarin absorption in a patient with short bowel syndrome. Clin Pharm 1985; 4: 325–6.

Kearns PJ O'Reilly RA . Bioavailability of warfarin in a patient with severe short bowel syndrome. J Parenter Enter Nutr 1986; 10: 100–1.

Wagner JG Welling PG Lee KP Walker JE . In vivo and in vitro availability of commercial warfarin tablets. J Pharm Sci 1971; 60: 666–77.

Lutomski DM Lafrance J Bower RH Fischer JE . Warfarin absorption after massive small bowel resection. Am J Gastroenterol 1985; 80: 99–102.

Musa MN Lyons LL . Absorption and disposition of warfarin: Effects of food and liquids. Curr Ther Res 1976; 20: 630–3.

Troleandomycin. In: McEvoy GK Mcquarrie GM , eds. American hospital formulary service drug information 87. Bethesda, MD: American Society of Hospital Pharmacists, 1987: 326–7.

Kaplan MA Goldin M . The use of triacetyloleandomycin in chronic infectious asthma. In: Welch H Marti-Ibanez F , eds. Antibiotics annual 1958–59. New York: Medical Encyclopedia, 1959: 273–6.

Fox JL . Infectious asthma treated with triacetyloleandomycin. Penn Med J 1961; 62: 634–5.

Itkin IH Menzel ML . The use of macrolide antibiotic substances in the treatment of asthma. J Allergy 1970; 45: 146–62.

Eitches RW Rachelefsky GS Katz RM Mendoza GR Siegel SC . Methylprednisolone and troleandomycin in treatment of steroid-dependent asthma in children. Am J Dis Child 1985; 139: 264–8.

Zeiger RS Schatz M Sperling W Simon RA Stevenson DD . Efficacy of troleandomycin in outpatients with severe, corticosteroid-dependent asthma. J Allergy Clin Immunol 1980; 66: 438–46.

Wald JA Friedman BF Farr RS . An improved protocol for the use of troleandomycin in the treatment of steroid-requiring asthma. J Allergy Clin Immunol 1986; 78: 36–43.

Spector SL Katz FH Farr RS . Troleandomycin: Effectiveness in steroid-dependent asthma and bronchitis. J Allergy Clin Immunol 1974; 54: 367–79.

Mendoza GR Eitches RW Orner FB . Direct effects of oleandomycin on histamine release in human basophils (abstract). J Allergy Clin Immunol 1983; 71: 135.

Pessayre D Larrey D Vitaux J Breil P Belghitti J Benhamou P . Formation of an inactive cytochrome P-450 Fe(II)-metabolite complex after administration of troleandomycin in humans. Biochem Pharmacol 1982; 31: 1699–704.

Weinberger M Hudgel D Spector S Chidsey C . Inhibition of theophylline clearance by troleandomycin. J Allergy Clin Immunol 1977; 59: 228–31.

Ludden TM . Pharmacokinetic interactions of the macrolide antibiotics. Clin Pharmacokinet 1985; 10: 63–79.

Szefler SJ Rose JQ Ellis EF Spector SL Green AW Jusko WJ . The effect of troleandomycin on methylprednisolone elimination. J Allergy Clin Immunol 1980; 66: 447–51.

Laforce CF Szefler SJ Miller MF Ebling W Brenner M . Inhibition of methylprednisolone elimination in the presence of erythromycin therapy. J Allergy Clin Immunol 1983; 72: 34–9.

Szefler SJ Brenner M Jusko WJ . Dose- and time-related effect of troleandomycin on methylprednisolone elimination. Clin Pharmacol Ther 1982; 32: 166–71.

Szefler SJ Ellis EF Brenner M . Steroid-specific and anticonvulsant interaction aspects of troleandomycin-steroid therapy. J Allergy Clin Immunol 1982; 69: 455–60.

Robinson MM . Hepatic dysfunction associated with triacetyloleandomycin and propionyl erythromycin ester lauryl sulfate. Am J Med Sci 1962; 142: 502–9.

Dasgupta A Marcoux JP . Hepatic abnormalities associated with long-term use of troleandomycin in asthma: A case report. Ann Allergy 1978; 41: 297–8.

Engel MF . Liver function studies in long-term triacetyloleandomycin therapy. South Med J 1963; 56: 1279–82.

Ticktin HE Zimmerman HJ . Hepatic dysfunction and jaundice in patients receiving troleandomycin. New Engl J Med 1962; 267: 964–8.

Dravet C Mesdjian E Cenraud B Roger J . Interaction between carbamazepine and troleandomycin (letter). Lancet 1977; 1: 810–1.

Mesdjian E Dravet C Cenraud B Roger J . Carbamazepine intoxication due to triacetyloleandomycin administration in epileptic patients. Epilepsia 1980; 21: 489–96.

Warot D Bergougnan L Lamiable D . Troleandomycin-triazolam interaction in healthy volunteers: Pharmacokinetic and psychometric evaluation. Eur J Clin Pharmacol 1987; 32: 389–93.

Findley LJ Koller WC . Essential tremor: A review. Neurology 1987; 37: 1194–7.

Adams RD Victor M . Principles of neurology. 3rd ed. New York: McGraw-Hill, 1985: 78.

Morgan MH Hewer RL Cooper R . Effect of the beta adrenergic blocking agent propranolol on essential tremor. J Neurol Neurosurg Psychiatry 1973; 36: 618–24.

Winkler GF Young RR . Efficacy of chronic propranolol therapy in action tremors of the familial, senile or essential varieties. N Engl J Med 1974; 290: 984–8.

Calzetti S Findley LJ Gresty MA Perucca E Richens A . Effect of a single oral dose of propranolol on essential tremor: A double-blind controlled study. Ann Neurol 1983; 13: 165–71.

Calzetti S Findley LJ Perucca E Richens A . The response of essential tremor to propranolol: Evaluation of clinical variables governing its efficacy on prolonged administration. J Neurol Neurosurg Psychiatry 1983; 46: 393–8.

Koller WC . Long-acting propranolol in essential tremor. Neurology 1985; 35: 108–10.

Koller WC . Dose-response relationship of propranolol in the treatment of essential tremor. Arch Neurol 1986; 43: 42–3.

Calzetti S Findley LJ Gresty MA Perucca E Richens A . Metoprolol and propranolol in essential tremor: A double-blind, controlled study. J Neurol Neurosurg Psychiatry 1981; 44: 814–9.

Calzetti S Findley LJ Perucca E Richens A . Controlled study of metoprolol and propranolol during prolonged administration in patients with essential tremor. J Neurol Neurosurg Psychiatry 1982; 45: 893–7.

Dietrichson P Espen E . Effects of timolol and atenolol on benign essential tremor: Placebo-controlled studies based on quantitative tremor recordings. J Neurol Neurosurg Psychiatry 1981; 44: 677–83.

Jefferson D Jenner P Mardsen CD . Beta-adrenoreceptor antagonists in essential tremor. J Neurol Neurosurg Psychiatry 1979; 42: 904–9.

Britt CW Peters BH . Metoprolol for essential tremor (letter). N Engl J Med 1979; 301: 331.

Riley T Pleet AB . Metoprolol tartrate for essential tremor (letter). N Engl J Med 1979; 301: 663.

Turnbull DM Shaw DA . Metoprolol in essential tremor (letter). Lancet 1980; 1: 95.

Newman RD Jacobs L . Metoprolol in essential tremor. Arch Neurol 1980; 37: 596–7.

Graham DM . Caffeine—its identity, dietary sources, intake and biological effects. Nutr Rev 1978; 36: 97–102.

Brazier JL Ritter J Berland M . Pharmacokinetics of caffeine during and after pregnancy. Dev Pharmacol Ther 1983; 6: 315–22.

Kirkinen P Jouppila P Kiovula A . The effect of caffeine on placental and fetal blood flow in human pregnancy. Am J Obstet Gynecol 1983; 147: 939–42.

Goldstein A Warren R . Passage of caffeine into human and fetal tissue. Biochem Pharmacol 1962; 59: 166–8.

Soyka LF . Caffeine ingestion during pregnancy. In utero exposure and possible effects. Semin Perinatol 1981; 5: 305–9.

Morris MB Weinstein L . Caffeine and the fetus: Is trouble brewing? Am J Obstet Gynecol 1981; 140: 607–10.

Wilson JG Scott WJ Jr . The teratogenic potential of caffeine in laboratory animals. In: Dews PB , ed. Caffeine: Perspectives from recent research. Berlin: Springer-Verlag, 1984: 165–87.

Weathersbee PS Olsen LK Lodge JR . Caffeine and pregnancy. Postgrad Med 1977; 62: 64–9.

Lechat MF Borlee I Bouckaert A . Caffeine study (letter). Science 1980; 207: 1296–7.

Jacobson MF Goldman AS Syme RH . Coffee and birth defects (letter). Lancet 1981; 1: 1415–6.

Furuhashi N Sato S Suzuki M . Effects of caffeine ingestion during pregnancy. Gynecol Obstet Invest 1985; 19: 187–91.

Linn S Schoenbaum SC Monson RR . No association between coffee consumption and adverse outcome of pregnancy. N Engl J Med 1982; 306: 141–5.

Leviton A . Epidemiological studies of birth defects. In: Dews PB , ed. Caffeine: Perspectives from recent research. Berlin: Springer-Verlag, 1984: 188–200.

Rosenberg L Mitchell MD Shapiro S . Selected birth defects in relation to caffeine-containing beverages. JAMA 1982; 247: 1429–32.

Kurppa K Holmberg PC Kuosma E . Coffee consumption during pregnancy and selected congenital malformations: A nationwide case-control study. Am J Public Health 1983; 73: 1397–9.

Whitehead R Piris J . Morphological aspects of non-ulcer dyspepsia. In: Wastell C Lance P , eds. Cimetidine: The Westminster Hospital Symposium. London: Churchill Livingstone, 1978: 111–24.

Labrooy S Lovell D Misiewicz JJ . The treatment of non-ulcer dyspepsia. In: Wastell C Lance P , eds. Cimetidine: The Westminster Hospital Symposium. London: Churchill Livingstone, 1978: 131–40.

Mackinnon M Willing RL Whitehead R . Cimetidine in the management of symptomatic patients with duodenitis. Dig Dis Sci 1982; 27: 217–9.

Nicopoulos N Vassilakis JJ Stathopoulos E Mantidis A . Ulcer associated and non-specific duodenitis treatment by cimetidine. Gastroenterol Jpn 1987; 17: 214–7.

Nesland AA Berstad A . Effect of cimetidine in patients with non-ulcer dyspepsia and erosive pre-pyloric changes. Scand J Gastroenterol 1985; 20: 629–35.

Delattre M Malesky M Prinzie A . Symptomatic treatment of non-ulcer dyspepsia with cimetidine. Curr Ther Res 1985; 37: 980–91.

Casiraghi A Ferrara A Lesinigo E . Cimetidine vs. antacids in non-ulcer dyspepsia. Curr Ther Res 1986; 39: 388–96.

Talley NJ McNeil D Hayden A Piper DW . Randomized double-blind placebo controlled crossover trial of cimetidine and pirenzepine in non-ulcer dyspepsia. Gastroenterology 1986; 91: 149–56.

Lance P Wastell C Schiller KFR . A controlled trial of cimetidine for the treatment of non-ulcer dyspepsia. J Clin Gastroenterol 1986; 8: 414–8.

Nyren O Adami H Bates S . Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med 1986; 314: 339–43.

Kelbaeck H Linde J Ericksen J Munkgaard S Moesgaard F Bonnevie O . Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia. Acta Med Scand 1985; 217: 281–7.